News

Prevent Blindness America’s Most Beautiful Eyes Contest emphasizes that keeping children’s eyes and vision healthy should be a priority for everyone.

The LEITR 2012 Eye Ball Gala helps raise approximately $125,000 and showcases the need for ocular advancements and research for the blind and visually impaired.

KalVista Pharmaceuticals has received a £2.4 million grant to accelerate development of an oral plasma kallikrein inhibitor for the treatment of diabetic macular edema.

Focal lamina cribrosa defects were highly correlated with glaucomatous structural and functional damage in an evaluation performed with EDI-OCT.

Results from recent multicenter randomized clinical trials are providing glaucoma surgeons with valuable information to guide their use of aqueous shunts.

Preliminary results from a retrospective multicenter chart review study provide further insight on the long-term outcomes after keratoprosthesis surgery.

Intravitreal injection of aflibercept provides marked improvement in visual acuity in treatment-naive eyes with macular edema secondary to central retinal vein occlusion in results from follow-up to 76 weeks in the phase III GALILEO study.

Intraoperative wavefront aberrometry has been a helpful tool for refining refractive outcomes after cataract surgery in the difficult group of eyes with a history of refractive surgery.

A partnership with Escalon Medical Corp. and Modernizing Medicine Inc. aims to provide cloud-based, end-to-end electronic medical records and image management solutions for ophthalmic practices.

Reichert's next-generation ultrasound biomicroscope offers a larger viewing area, a user-friendly, touch-screen interface, and software improvements.

During this week's meeting of the American Academy of Ophthalmology, several ophthalmic organizations are asking health-care professionals to join them in giving the gift of life by registering as eye, organ, and tissue donors.

A review of experience with the first 850 cases of laser-assisted cataract surgery using a proprietary femtosecond laser system highlights advantages for using the technology in routine and challenging cases.

A new refraction system based on point spread function provided better or equal accuracy and reliability in refractive endpoints compared with a standard phoropter in a study.

Data from a study designed to compare satisfaction with LASIK and contact lenses for vision correction provides important and somewhat surprising information on the experience of established contact lens wearers.

A microdroplet fluid ejection device is a promising new technology for topical delivery of ophthalmic medications.

Carl Zeiss Meditec introduces new optical coherence tomography platforms that span the full spectrum of multi-modality imaging for glaucoma and retinal disease.

Though the association of aspirin use and age-related macular degeneration is controversial, the totality of evidence suggests there is no major harmful effect of aspirin use.

Results from studies of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration can be interpreted in a variety of ways, depending on the baseline bias of the individual.

Quantel Medical has received FDA 510(k) market clearance of its ophthalmic laser system (SupraScan 577 Laser) for treating a wide range of retinal diseases.

Recently introduced microinvasive glaucoma surgery procedures are easy enough to be performed by cornea specialists, but the need for close surveillance of the patient with glaucoma must be kept in mind.

There are a variety of new diagnostic tests for dry eye and a number of reasons to incorporate these technologies into practice.

The Ophthalmology Innovation Summit provides a forum for the leaders of ophthalmology to look at all aspects of the innovation process to create additional innovation and to circumvent issues that hinder that innovation.

Quantel Medical and Iridex have signed a global patent licensing agreement that gives Quantel access to Iridex's MicroPulse technology.

Heidelberg Engineering has received FDA clearance for its MultiColor scanning laser imaging as a new dimension in multi-modality fundus imaging with the Spectralis product family.

Results of a retrospective, observational, multicenter study including 140 eyes demonstrate the safety and efficacy of phakic IOL explantation surgery.

A new wavefront-guided LASIK procedure provides superior cylinder correction, better uncorrected visual acuity outcomes, and slightly higher patient satisfaction.

Preliminary results of a preclinical study investigating the effect of peripheral collagen crosslinking on the limbal stem cells provide some reassurance about the safety of the technique.

EyeGate Pharma’s broad iontophoresis patent portfolio for corneal collagen cross-linking will be held as exclusive license by Avedro Inc. Delivery approach provides potential additional benefits to current formulation.

Prevent Blindness America offers free educational materials to help the public, educators, and health professionals address diabetes and its visual consequences.

In a pilot phase II study, an intracanalicular plug (OTX-TP2, Ocular Therapeutics) shows promise for lowering IOP and increasing compliance with the treatment regimen.